Altered renal medullary blood flow: A key factor or a parallel event in control of sodium excretion and blood pressure?
Autor: | Bożena Bądzyńska, Janusz Sadowski |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
0301 basic medicine medicine.medical_specialty Physiology Hydrostatic pressure Blood Pressure Context (language use) Vasodilation Renal Circulation Natriuresis 03 medical and health sciences 0302 clinical medicine Physiology (medical) Internal medicine Renal medulla Animals Medicine Pharmacology business.industry Sodium Blood flow Lipid Metabolism Medullipin Rats 030104 developmental biology medicine.anatomical_structure Blood pressure Endocrinology 030220 oncology & carcinogenesis business |
Zdroj: | Clinical and Experimental Pharmacology and Physiology. 47:1323-1332 |
ISSN: | 1440-1681 0305-1870 |
DOI: | 10.1111/1440-1681.13303 |
Popis: | In the context of the ongoing debate on the mechanism of blood pressure (BP) regulation and pathophysiology of arterial hypertension ("renocentric" vs "neural" concepts), attention is focused on the putative regulatory role of changes in renal medullary blood flow (MBF). Experimental evidence is analysed with regard to the question whether an elevation of BP and renal perfusion pressure (RPP) is likely to increase MBF due to its impaired autoregulation. It is concluded that such increases have been clearly documented only in rats with extracellular fluid volume expansion. A possible translation of this finding to BP regulation in health and hypertension in humans may only be a matter of speculation. Within the "renocentric" theory, the key event leading to restoration of initial BP level is pressure natriuresis. Its relation to elevation of renal interstitial hydrostatic pressure and to the phenomenon of "wash-out" of renal medullary solutes by increasing MBF is discussed. We also assessed the validity of data supporting the putative mechanism of short-term restoration of elevated BP owing to the release of a vasodilator lipid (medullipin) by the medulla. The structure of the proposed medullary lipid is still undefined, and there is no sound evidence on its mediatory role in lowering elevated BP level. In conclusion, MBF change can hardly be regarded as a crucial event in the regulation of BP: it can be involved in the control of sodium excretion and BP only in some circumstances, although its contributory role cannot be excluded. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |